{"disease":{"id":"lupus-glomerulonephritis","name":"lupus glomerulonephritis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03929887","title":"KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT03201406","title":"Retrospective Analysis of Renal Prognosis in Patients With Chronic Kidney Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":837,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT06757725","title":"Renal Resistive Index as an Indicator of Lupus Nephritis Severity and Systemic Lupus Activity","phase":"NA","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Kasr El Aini Hospital","has_results":false},{"nct_id":"NCT03453619","title":"Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Apellis Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT07000292","title":"MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":12,"lead_sponsor_name":"Shanghai Changzheng Hospital","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}